Top Clinical Trials companies in Sweden by Gross Profit Margin
Sweden
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
113.38%
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
| 2 |
100.00%
|
Dec. 31, 2023 | USD 2.74 | 1.67% |
|
Sweden |
|
| 3 |
100.00%
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
| 4 |
100.00%
|
Dec. 31, 2023 | USD 0.71 | -2.02% |
|
Sweden |
|
| 5 |
100.00%
|
Dec. 31, 2023 | USD 0.10 | 0.68% |
|
Sweden |
|
| 6 |
100.00%
|
Dec. 31, 2023 | USD 1.17 | -3.73% |
|
Sweden |
|
| 7 |
100.00%
|
Dec. 31, 2023 | USD 0.45 | 23.08% |
|
Sweden |
|
| 8 |
100.00%
|
Dec. 31, 2023 | USD 0.39 | 2.53% |
|
Sweden |
|
| 9 |
99.90%
|
Dec. 31, 2023 | USD 0.23 | 11.53% |
|
Sweden |
|
| 10 |
85.45%
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
| 11 |
52.91%
|
Dec. 31, 2023 | USD 2.91 | -2.20% |
|
Sweden |
|
| 12 |
36.23%
|
Dec. 31, 2023 | USD 0.28 | -7.61% |
|
Sweden |
|
| 13 |
-384.02%
|
Dec. 31, 2023 | USD 0.21 | 0.68% |
|
Sweden |
|
| 14 |
-410.21%
|
Aug. 31, 2024 | USD 0.22 | -6.29% |
|
Sweden |
|
| 15 |
-1,334.07%
|
Dec. 31, 2023 | USD 0.80 | 0.68% |
|
Sweden |
|
| 16 |
-2,161.57%
|
Dec. 31, 2023 | USD 0.90 | 9.88% |
|
Sweden |
|
| 17 |
-2,753.85%
|
Aug. 31, 2024 | USD 1.61 | 0.34% |
|
Sweden |
|
| 18 |
-4,773.23%
|
Dec. 31, 2023 | USD 0.20 | 1.12% |
|
Sweden |
Frequently Asked Questions
-
Which Clinical Trials company in Sweden has the highest Gross Profit Margin ?
The Clinical Trials company in Sweden with the highest Gross Profit Margin is Corline Biomedical AB (Stockholm Stock Exchange: CLBIO.ST) at 113.38%.
-
Which Clinical Trials company in Sweden has the lowest Gross Profit Margin ?
The Clinical Trials company in Sweden with the lowest Gross Profit Margin is Isofol Medical AB (publ) (Stockholm Stock Exchange: ISOFOL.ST) at -4,773.23%.
-
What are the top 10 Clinical Trials companies in Sweden by Gross Profit Margin ?
The top 10 Clinical Trials companies in Sweden by Gross Profit Margin are Corline Biomedical AB, BioInvent International AB (publ), Aptahem AB (publ), Mendus AB (publ), Kancera AB (publ), Lipum AB (publ), OncoZenge AB (publ), Pila Pharma AB (publ), Elicera Therapeutics AB (publ) and BioArctic AB (publ).
-
What are the bottom 10 Clinical Trials companies in Sweden by Gross Profit Margin ?
The bottom 10 Clinical Trials companies in Sweden by Gross Profit Margin are Isofol Medical AB (publ), Diamyd Medical AB (publ), IRLAB Therapeutics AB (publ), Prostatype Genomics AB (publ), NextCell Pharma AB, CombiGene AB (publ), Clinical Laserthermia Systems AB (publ), Hansa Biopharma AB (publ), BioArctic AB (publ) and Elicera Therapeutics AB (publ).